Harry Drabkin

538 total citations
11 papers, 441 citations indexed

About

Harry Drabkin is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, Harry Drabkin has authored 11 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Genetics and 2 papers in Surgery. Recurrent topics in Harry Drabkin's work include Genomic variations and chromosomal abnormalities (3 papers), Cancer-related Molecular Pathways (2 papers) and Protein Degradation and Inhibitors (2 papers). Harry Drabkin is often cited by papers focused on Genomic variations and chromosomal abnormalities (3 papers), Cancer-related Molecular Pathways (2 papers) and Protein Degradation and Inhibitors (2 papers). Harry Drabkin collaborates with scholars based in United States, Italy and Japan. Harry Drabkin's co-authors include Robert M. Gemmill, Patrick Nasarre, Akira Yokomizo, Wilbur A. Franklin, Donald J. Tindall, Jeremy C. Smith, Wanguo Liu, Paul A. Erickson, Elihu H. Estey and J. M. Trujillo and has published in prestigious journals such as Blood, The Journal of Clinical Endocrinology & Metabolism and Oncogene.

In The Last Decade

Harry Drabkin

11 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harry Drabkin United States 10 313 96 91 52 50 11 441
LA Falk United States 6 274 0.9× 111 1.2× 97 1.1× 21 0.4× 38 0.8× 8 423
N M Sposi Italy 13 275 0.9× 212 2.2× 78 0.9× 19 0.4× 54 1.1× 21 542
Scott Langdon United States 11 189 0.6× 56 0.6× 31 0.3× 45 0.9× 36 0.7× 15 358
G J Mavrothalassitis United States 9 344 1.1× 57 0.6× 72 0.8× 21 0.4× 63 1.3× 10 461
Wendy Fang United States 9 383 1.2× 124 1.3× 100 1.1× 20 0.4× 25 0.5× 17 563
Thomas Cauvet Germany 8 439 1.4× 116 1.2× 146 1.6× 18 0.3× 31 0.6× 8 597
Daniel Fitzsimmons United States 11 396 1.3× 44 0.5× 115 1.3× 33 0.6× 65 1.3× 14 660
Peter Haviernik United States 13 297 0.9× 89 0.9× 88 1.0× 23 0.4× 58 1.2× 25 441
M C Gendron France 12 242 0.8× 82 0.9× 27 0.3× 15 0.3× 40 0.8× 20 397
Tim Pieters Belgium 12 421 1.3× 91 0.9× 78 0.9× 14 0.3× 54 1.1× 26 563

Countries citing papers authored by Harry Drabkin

Since Specialization
Citations

This map shows the geographic impact of Harry Drabkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Drabkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Drabkin more than expected).

Fields of papers citing papers by Harry Drabkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry Drabkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Drabkin. The network helps show where Harry Drabkin may publish in the future.

Co-authorship network of co-authors of Harry Drabkin

This figure shows the co-authorship network connecting the top 25 collaborators of Harry Drabkin. A scholar is included among the top collaborators of Harry Drabkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry Drabkin. Harry Drabkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Drabkin, Harry, Patrick Nasarre, & Robert M. Gemmill. (2014). The emerging role of class-3 semaphorins and their neuropilin receptors in oncology. OncoTargets and Therapy. 7. 1663–1663. 69 indexed citations
2.
Puig‐Kröger, Amaya, Tilman Sánchez-Elsner, Natividad Ruiz, et al.. (2003). RUNX/AML and C/EBP factors regulate CD11a integrin expression in myeloid cells through overlapping regulatory elements. Blood. 102(9). 3252–3261. 41 indexed citations
3.
Yokomizo, Akira, Donald J. Tindall, Harry Drabkin, et al.. (1998). PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers. Oncogene. 17(4). 475–479. 143 indexed citations
4.
Varella-Garcia, M., Sílvia Helena Barem Rabenhorst, Jonathan S. Wiest, et al.. (1997). 547 Complex abnormalities involving chromosomal regions 3p and 9p in non-small cell lung cancer (NSCLC) revealed by fluorescence in situ hybridization (FISH). Lung Cancer. 18. 140–140. 1 indexed citations
5.
Gelbert, Lawrence M., Ernestina Schipani, H. Jüppner, et al.. (1994). Chromosomal localization of the parathyroid hormone/parathyroid hormone-related protein receptor gene to human chromosome 3p21.1-p24.2.. The Journal of Clinical Endocrinology & Metabolism. 79(4). 1046–1048. 13 indexed citations
6.
Chang, Kun‐Sang, Sanford A. Stass, Elihu H. Estey, et al.. (1993). Expression of AML1-ETO fusion transcripts and detection of minimal residual disease in t(8;21)-positive acute myeloid leukemia.. PubMed. 8(4). 983–8. 69 indexed citations
7.
Gao, Jizong, et al.. (1991). Isolation and regional mapping of NotI and EagI clones from human chromosome 21. Genomics. 10(1). 166–172. 12 indexed citations
8.
Barletta, C, Teresa Druck, Sal LaForgia, et al.. (1991). Chromosome locations of the MYB related genes, AMYB and BMYB.. PubMed. 51(14). 3821–4. 12 indexed citations
9.
Stewart, Gordon D., Gerard P. McNeil, Sayon Roy, et al.. (1988). Isolation of DNA sequences on human chromosome 21 by application of a recombination-based assay to DNA from flow-sorted chromosomes. Human Genetics. 79(3). 196–202. 17 indexed citations
10.
Rao, V. N., W.S. Modi, Harry Drabkin, et al.. (1988). The human erg gene maps to chromosome 21, band q22: relationship to the 8; 21 translocation of acute myelogenous leukemia.. PubMed. 3(5). 497–500. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026